acetobacter
Cell therapyexperimental
Acetobacter is a genus of acetic acid bacteria. Acetic acid bacteria are characterized by the ability to convert ethanol to acetic acid in the presence of oxygen. Of these, the genus Acetobacter is distinguished by the ability to oxidize lactate and acetate into carbon dioxide and water. Bacteria of the genus Acetobacter have been isolated from industrial vinegar fermentation processes and are frequently used as fermentation starter cultures. — Wikipedia
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 15, 2015 (NCT03614039)
Timeline
No events for the selected filters.
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaAcetobacter ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04293731 | N/A | Nov 1, 2018 | Bogomolets National Medical University, Taras Shevchenko National University of Kyiv |
| NCT04201938 | N/A | Feb 1, 2018 | Bogomolets National Medical University, Taras Shevchenko National University of Kyiv |
| NCT03614039 | N/A | Sep 15, 2015 | Bogomolets National Medical University |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Bogomolets National Medical University | Academic/Hospital | 3 | 3 | 1 | 2015 |
| Taras Shevchenko National University of Kyiv | Academic/Hospital | 2 | 0 | 1 | 2018 |
2 organizations
Page 1 / 1